General Features of Liver Disease

Slide 1 · The liver: a large reserve organ

Hepatic disease may remain clinically occult until substantial functional disruption develops.

Primary or secondary insult

Hepatic injury

Functional reserve

Clinical manifestations

Many injuries initially cause no recognizable symptoms.

Diffuse progression or bile-flow disruption changes the clinical picture.

A laboratory abnormality may precede decompensation.

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Organize liver disease from anatomy and exposure to functional expression.

Architecture

Portal tracts, central veins and sinusoidal exchange

Etiology

Primary and secondary categories of hepatic injury

Course

Functional reserve, silent injury and decompensation

Evaluation

Integrity, excretory, synthetic and metabolic tests

Locate the principal structures of a hepatic lobule.

Distinguish the broad etiologic categories of liver injury.

Classify commonly measured liver laboratory tests.

Slide 3 · Liver pathology: Three linked questions

A structural lesion, impaired physiology and the clinical syndrome need not appear simultaneously.

What injured the liver?

Where is the damage?

Which function is altered?

Etiologic classification does not establish functional severity.

Anatomic distribution influences the consequence of injury.

Symptoms depend on reserve, disease extent and biliary flow.

Slide 4 · Normal adult liver: Anatomical baseline

The source describes a normal adult liver mass of approximately 1400–1600 g.

Mass

Normal adult liver: 1400–1600 g

Organization

Portal inflow → sinusoids → hepatic venous drainage

An organ-level change must be interpreted against its normal architecture.

Parenchymal cells and biliary channels form linked but distinct networks.

Vascular supply and outflow help explain injury distribution.

Slide 5 · Dual blood supply

The hepatic circulation combines portal venous and arterial inflow.

Portal vein

Accounts for 60%–70% of hepatic blood flow

Hepatic artery

Accounts for the remaining 30%–40%

The two inflows mix in the hepatic sinusoids.

Both vessels reach the liver through the porta hepatis.

A gradient of oxygen availability is established across the acinus.

Slide 6 · The porta hepatis is a shared gateway

Portal veins, hepatic arteries and bile ducts travel together within portal tracts.

Porta hepatis

Portal tract branches

Parenchymal microcirculation

The portal vein and hepatic artery enter at the inferior liver surface.

The vascular branches continue in parallel with bile ducts.

Portal-tract identification is fundamental to liver histology.

Slide 7 · Identify the portal tract

Three structures define the major portal-tract components.

Portal vein branch

Hepatic artery branch

Interlobular bile duct

Portal venous and hepatic arterial branches supply blood.

The interlobular bile duct belongs to the biliary drainage system.

These structures appear together at the lobular periphery.

Slide 8 · The classical hepatic lobule

A hexagonal organizational model centers on a terminal hepatic vein.

CV

Portal tracts at periphery

Schematic: Classic lobule

The textbook lobular model spans approximately 1–2 mm.

Central veins occupy the center of the lobular model.

Portal tracts mark the peripheral vertices.

Slide 9 · Hepatocyte plates form a connected mesh

Liver cells are organized in anastomosing sheets that span portal and central regions.

Portal tract

Hepatocyte plates

Central vein

Plates are interleaved with vascular sinusoids.

This arrangement gives hepatocytes access to circulating substrates.

Loss of normal architecture can impair several functions at once.

Slide 10 · Sinusoids are vascular conduits

Blood passes between hepatocyte plates toward terminal hepatic veins.

SINUSOID → blood toward central vein

Fenestrated endothelium

Space of Disse

Hepatocyte plates

Sinusoidal blood contains a mixture of portal and arterial inflow.

Sinusoidal endothelial cells are fenestrated.

The fenestrated lining facilitates communication with hepatocytes.

Slide 11 · Two-sided exposure of hepatocytes

Anastomosing plates allow hepatocytes to interface with sinusoidal blood on two sides.

Sinusoidal face

Access to mixed portal and arterial blood

Canalicular face

Secretion into a separate bile pathway

Vascular exchange and bile secretion are functionally distinct.

The same cell participates in both systems.

Hepatocellular damage may affect either or both functions.

Slide 12 · Fenestrated sinusoidal endothelium

The sinusoidal lining separates blood from the space of Disse.

Blood in sinusoid

Fenestrated endothelium

Space of Disse

Hepatocyte microvilli

The endothelium is not a conventional continuous barrier.

The subendothelial compartment is the space of Disse.

Hepatocyte microvilli extend into this exchange compartment.

Slide 13 · Space of Disse: An exchange interface

The perisinusoidal compartment lies between hepatocytes and endothelial cells.

Blood in sinusoid

Fenestrated endothelium

Space of Disse

Hepatocyte microvilli

Hepatocyte microvilli project into this space.

Lipid-containing stellate cells are present here.

Its location places stellate cells near injured hepatocytes.

Slide 14 · Kupffer cells: Sinusoidal macrophages

Resident macrophages occupy the luminal face of sinusoidal endothelial cells.

SINUSOID → blood toward central vein

Fenestrated endothelium

Space of Disse

Hepatocyte plates

Kupffer cells are anatomically positioned to sample circulating material.

Injury-associated debris is cleared by hepatic macrophages.

Immune and parenchymal responses can occur in close proximity.

Slide 15 · Stellate cells: Normal storage role

Quiescent hepatic stellate cells store lipids, including vitamin A.

Baseline

Lipid-containing stellate cells in the space of Disse

With injury

Can acquire fibrogenic myofibroblast features

Stellate cells occupy the perisinusoidal space.

Their altered state contributes to fibrosis during sustained injury.

Persistent injury can redirect stellate cells toward collagen deposition.

Slide 16 · Normal hepatic immune residents

Lymphocytes are present even in the uninjured liver.

γδ T cells

Prominent resident lymphocyte population

NK cells

Contribute to the local lymphoid compartment

Distribution

Near biliary tracts and within sinusoids

γδ T cells and natural killer cells occur in normal hepatic tissue.

Their presence alone does not establish hepatitis.

Interpret inflammatory changes in anatomical context.

Slide 17 · Bile canaliculi: A distinct network

Canaliculi form between adjacent hepatocytes.

Hepatocyte canaliculi

Canals of Hering

Ductules

Interlobular ducts

Canalicular channels lie at interhepatocellular interfaces.

They connect to the canals of Hering.

They are separate from the blood-filled sinusoids.

Slide 18 · Tight junctions separate vascular and bile compartments

The canalicular lumen must remain segregated from the sinusoidal exchange space.

Sinusoidal compartment

Blood and exchanged solutes near the hepatocyte

Canalicular compartment

Bile secretion between neighboring hepatocytes

Adjacent hepatocyte membranes form the canalicular lumen.

Tight junctions maintain compartmental separation.

Disruption of secretion or flow contributes to cholestatic dysfunction.

Slide 19 · Bile follows a branching drainage route

Canaliculi feed progressively larger biliary channels.

Hepatocyte canaliculi

Canals of Hering

Ductules

Interlobular ducts

Canaliculi drain into the canals of Hering.

Canals of Hering communicate with bile ductules.

Ductules lead to interlobular ducts within portal tracts.

Slide 20 · Blood flow versus bile flow

The vascular and bile circuits run in opposite functional directions.

Portal inflow

Central vein

Interlobular bile duct

Canaliculi

BLOOD

BILE

Blood travels from portal-tract inflow to central-vein outflow.

Bile is collected toward ducts in portal tracts.

This opposition is essential when localizing dysfunction.

Slide 21 · The hepatic acinus models perfusion

Acinar zones are defined relative to the incoming blood supply.

Portal tract

Zone 1

Zone 2

Zone 3

Blood flow →

CV

Schematic: Portal-to-central gradient

Zone 1 lies nearest the portal-tract inflow.

Zone 3 lies closest to the central vein.

Zone 2 represents an intervening region.

Slide 22 · Acinar zone 1: Periportal

Zone 1 has the highest oxygenation in the hepatic acinus.

Portal tract

Zone 1

Zone 2

Zone 3

Blood flow →

CV

Schematic: Portal-to-central gradient

It receives blood before downstream pericentral regions.

Relative oxygen delivery contributes to zonal physiological differences.

Zonal terminology should be linked to a visible landmark.

Slide 23 · Acinar zone 3: Pericentral

Zone 3 is the region farthest from the portal inflow.

Portal tract

Zone 1

Zone 2

Zone 3

Blood flow →

CV

Schematic: Portal-to-central gradient

It has the lowest oxygenation of the three zones.

Its location influences vulnerability in certain injuries.

In the classical lobule, it lies around the central vein.

Slide 24 · An oxygen gradient exists across the acinus

Blood traverses zones with progressively different oxygen availability.

Portal tract: Higher O₂

Intervening zone

Central region: Lower O₂

Zone 1 oxygenation exceeds zone 3 oxygenation.

The gradient arises from the geometry of perfusion.

Zonal sensitivity is not identical for every cause of injury.

Slide 25 · Metabolic heterogeneity influences susceptibility

Hepatocytes are not metabolically identical from the periphery to the lobular center.

Oxygen availability

Varies from portal to central regions

Metabolic activity

Also differs across the lobular axis

Blood supply is one determinant of tissue vulnerability.

Cellular metabolic specialization provides another determinant.

Pattern recognition can point to a category of injury.

Slide 26 · Why injury distribution matters

The same organ can show preferential damage in different anatomical zones.

Regional physiology

Different susceptibility

Zonal injury pattern

Portal and central landmarks define the injury location.

Oxygenation and metabolism help explain regional damage.

A pattern is mechanistic evidence, not by itself a specific diagnosis.

Slide 27 · Primary hepatic disease: Five broad classes

Robbins groups primary liver disorders by the nature of the initiating insult.

Metabolic

Altered cellular metabolic processes

Toxic

Chemical or drug-associated exposure

Microbial

Infectious insult

Circulatory

Perfusion or vascular disturbance

Neoplastic

Abnormal proliferative disease

Interactions

More than one pathway may be present

Etiologic classification is the starting point for diagnosis.

Clinical severity is not predicted simply by the category name.

Primary and secondary injuries belong to different causal categories.

Slide 28 · Circulatory liver injury

Hepatic function depends on an intact inflow–sinusoid–outflow circuit.

Circulatory disturbance

Altered perfusion

Hepatic damage

Circulatory disorders as a primary category.

Normal vascular anatomy is essential for interpreting such injury.

Heart failure is also a source of secondary hepatic damage.

Slide 29 · Neoplastic involvement of the liver

Neoplasia may cause primary hepatic disease or represent spread from elsewhere.

Primary neoplastic disorder

Disease originates within the liver

Disseminated cancer

Hepatic damage is secondary to extrahepatic malignancy

A hepatic lesion need not be primary liver cancer.

Both neoplasia and disseminated cancer.

The cause must be distinguished from its site of manifestation.

Slide 30 · Heart failure: Systemic disease with hepatic consequences

Cardiac dysfunction is a named example of secondary liver injury.

Heart failure

Hepatic circulation affected

Secondary hepatic damage

The primary disorder is cardiac rather than hepatic.

The liver’s vascular connections make it vulnerable to systemic disease.

The liver may be the affected organ even when the primary disease is cardiac.

Slide 31 · Extrahepatic infection and hepatic dysfunction

An infection outside the liver may be accompanied by hepatic injury.

Extrahepatic infection

Systemic response

Liver involvement

The source lists extrahepatic infections as secondary causes.

An abnormal liver panel does not automatically imply hepatotropic infection.

Direct and indirect involvement must be considered separately.

Slide 32 · Primary versus secondary: Diagnostic framing

The liver can be either the origin of disease or an affected downstream organ.

Primary

Metabolic, toxic, microbial, circulatory or neoplastic liver disorder

Secondary

Heart failure, disseminated cancer or extrahepatic infection

Start with the systemic history, not only the liver panel.

Separate the initiating disease from hepatic consequences.

This distinction guides the differential diagnosis.

Slide 33 · Common potentially reversible hepatocyte changes

The adjacent injury-response section provides the microscopic vocabulary.

Steatosis

Fat accumulation within hepatocytes

Cholestasis

Bile-related pigment retention

Ballooning

Cell swelling, clearing and filament clumping

These changes reflect perturbed cell function.

None of the changes alone identifies every possible etiology.

Here they illustrate the spectrum preceding irreversible injury.

Slide 34 · Irreversible hepatocyte injury

Severe cellular damage can culminate in necrosis or apoptosis.

Necrosis

Swelling, membrane failure and cellular rupture

Apoptosis

Cell shrinkage and fragmentation into apoptotic bodies

Both processes remove functioning hepatocytes.

Membrane rupture differs from fragmentation into apoptotic bodies.

Extent and distribution influence organ-level consequences.

Slide 35 · Repair does not always restore architecture

Regeneration and scar formation are competing responses to sustained injury.

Hepatocyte loss

Regeneration

Persistent injury / fibrosis

Mature hepatocytes can replace lost hepatocytes.

Persistent injury may activate fibrogenic stellate cells.

Fibrosis alters the tissue response to repeated or sustained injury.

Slide 36 · A normal reserve may conceal early injury

That mild hepatic damage can have little immediate clinical impact.

Mild damage: Capacity maintained

Progressive diffuse injury: Reserve consumed

Decompensation: Homeostasis impaired

Clinical silence is compatible with ongoing tissue damage.

Organ reserve can delay symptomatic expression.

A lack of symptoms does not exclude liver disease.

Slide 37 · Diffuse disease has greater functional implications

Loss of function becomes consequential when disease progresses throughout the organ.

Limited injury

Consider residual functioning parenchyma

Diffuse progression

Broad loss or dysfunction of parenchyma threatens reserve

The source highlights progression of diffuse disease.

Anatomical extent and functional reserve interact.

Apparent symptom severity may lag behind tissue injury.

Slide 38 · Impaired bile flow is a distinct mechanism of illness

Dangerous dysfunction may occur with disruption of bile drainage, not only parenchymal loss.

Biliary flow disturbed

Impaired excretory pathway

Clinical consequences

Bile transport is distinct from vascular perfusion.

Robbins singles out disruption of bile flow.

Biliary measurements belong to excretory testing.

Slide 39 · Decompensation is a functional transition

The clinical threshold is failure to maintain necessary hepatic homeostasis.

Compensated: Reserve protects function

Subclinical abnormalities may accumulate

Decompensated: Dysfunction is apparent

Decompensation is not synonymous with first liver-cell injury.

It can emerge after a prolonged insidious process.

The timing depends on the disease course and remaining capacity.

Slide 40 · The insidious natural history of liver disease

Outside acute liver failure, symptoms can be delayed after injury begins.

Initiating injury

Silent interval

Abnormal tests

Recognized disease

Delays of weeks, months or many years.

The process may escape the patient’s notice.

Progressive injury can be found through testing before symptoms.

Slide 41 · Hepatic injury can ebb and flow

Clinical course need not be a monotonic decline.

Injury episode

Partial recovery

Recurrent injury

Accumulated effect

Fluctuating injury may remain imperceptible.

Temporal variation complicates a single snapshot assessment.

The clinical history and serial observations add context.

Slide 42 · Acute liver failure is the principal exception

Robbins separates acute liver failure from the usual slowly evolving presentation.

Usual disease course

Insidious progression; Symptoms may be delayed

Acute liver failure

Rapid severe hepatic dysfunction

Acute failure involves rapid impairment of hepatic function.

The general-features concept is delayed manifestation of many injuries.

Rapid failure should not be assumed for all liver disorders.

Slide 43 · Laboratory tests may identify occult disease

Abnormal biochemical tests can reveal injury before clinical decompensation.

Asymptomatic injury

Abnormal liver tests

Targeted assessment

Robbins directly links clinically silent damage with laboratory detection.

Different tests interrogate different physiological functions.

The result pattern helps frame, but does not alone establish, the cause.

Slide 44 · Four laboratory evaluation domains

Table 18.1 groups tests by the function or injury they represent.

Integrity

Cytosolic enzyme leakage

Excretion

Bilirubin, bile acids and biliary-associated enzymes

Synthesis

Albumin and coagulation-factor measures

Metabolism

Ammonia and demethylation function

Test categories measure different aspects of liver disease.

An abnormality in one domain need not imply equal impairment in another.

A complete assessment integrates laboratory and clinical context.

Slide 45 · Hepatocyte integrity: Cytosolic enzymes

Cell injury is reflected by increased circulating intracellular enzymes.

AST

Aspartate aminotransferase → increased

ALT

Alanine aminotransferase → increased

LDH

Lactate dehydrogenase → increased

AST, ALT and LDH in the integrity category.

These tests indicate hepatocellular damage.

They do not directly quantify residual synthetic capacity.

Slide 46 · Injury markers are not direct functional reserves

An elevated enzyme and reduced organ capacity answer different questions.

Integrity panel

Have hepatocytes released intracellular enzymes?

Function panel

Can the liver maintain excretion, synthesis and metabolism?

Robbins separates injury markers from synthetic and metabolic tests.

A cell-injury signal is not itself proof of failure.

Interpret the categories together rather than interchangeably.

Slide 47 · Bilirubin interrogates biliary excretion

Table 18.1 lists serum bilirubin among substances normally secreted in bile.

Bilirubin handling

Bile secretion pathway

Serum bilirubin measurement

Increased serum bilirubin can indicate impaired excretory handling.

Total bilirubin includes conjugated and unconjugated fractions.

Direct bilirubin is the conjugated component in the source table.

Slide 48 · Total versus direct bilirubin

Total and direct bilirubin do not represent interchangeable analytes.

Total bilirubin

Conjugated + unconjugated bilirubin

Direct bilirubin

Conjugated bilirubin as stated in Table 18.1

The fractions distinguish what is being measured.

Bilirubin belongs to the biliary excretory function domain.

Etiologic interpretation requires additional clinical information.

Slide 49 · Canalicular-associated enzymes

ALP and GGT are grouped with biliary excretory markers.

ALP

Serum alkaline phosphatase

GGT

Serum γ-glutamyl transpeptidase

Table 18.1 links both to canalicular plasma-membrane damage.

Both are expected to increase in the table’s disease context.

Together they differ conceptually from cytosolic aminotransferases.

Slide 50 · The excretory panel measures several compartments

Bilirubin, bile acids and canalicular enzymes are related but not identical.

Serum bilirubin

Excretory substrate

Urine bilirubin

Urinary analyte

Bile acids

Bile-secreted substances

ALP / GGT

Canalicular-associated enzymes

The table combines substances secreted in bile with membrane enzymes.

The measured entity determines the interpretation.

No single marker exhausts all aspects of biliary dysfunction.

Slide 51 · Albumin represents synthetic function

A decrease in circulating albumin appears under hepatocyte synthetic function.

Hepatocyte synthesis

Albumin secreted into blood

Serum albumin

Serum albumin is a synthesized protein marker.

Table 18.1 lists decreased albumin in liver disease.

Interpretation differs from enzymes released by injured cells.

Slide 52 · Coagulation proteins represent synthesis

Hepatic synthetic function with coagulation-factor production.

Fibrinogen

Protein secreted into blood

Prothrombin

Coagulation-factor precursor

Factor V / VII

Examples in the table

Factor IX / X

Additional table examples

Several coagulation proteins depend on hepatic synthesis.

The table places PT and PTT in the synthetic-function domain.

Decreased coagulation-factor production can alter clotting times.

Slide 53 · PT and PTT assess the coagulation pathway

Clotting times are functional readouts of multiple coagulation factors.

Reduced factor production

Coagulation capacity affected

PT / PTT may prolong

The table lists both PT and partial thromboplastin time (PTT).

Do not interpret the table’s “decreased” as shorter clotting times.

The decrease refers to factor production; Duration may lengthen.

Slide 54 · Synthetic function differs from integrity

Liver enzyme leakage and protein production describe separate physiological properties.

Hepatocyte integrity

AST, ALT and LDH increase after cell damage

Hepatocyte synthesis

Albumin and coagulation-factor production can decrease

An elevated transaminase alone does not prove synthetic failure.

Synthesis may change as functional capacity is lost.

Keep these measurement domains distinct.

Slide 55 · Ammonia is a metabolic-function measure

Serum ammonia appears under hepatic metabolism in Table 18.1.

Hepatic metabolism impaired

Ammonia handling altered

Serum ammonia may rise

The table lists serum ammonia as increasing in disease.

It is not a cytosolic enzyme-leakage measurement.

This test belongs to metabolism rather than hepatocyte-integrity measurement.

Slide 56 · Aminopyrine breath testing

Hepatic demethylation is presented as a distinct metabolic function.

Hepatic demethylation

Aminopyrine breath test

Reduced test result in disease

The source explicitly lists a hepatic demethylation breath test.

The expected change in the table is decreased.

It represents metabolic capacity, not cytosolic enzyme release.

Slide 57 · The full liver-test framework

A coherent interpretation starts with the physiologic question asked by each result.

Integrity

AST, ALT, LDH ↑

Excretion

Bilirubin, bile acids, ALP, GGT ↑

Synthesis

Albumin and factor production ↓

Metabolism

Ammonia ↑; Aminopyrine test ↓

Each domain captures a different aspect of liver disease.

Directional changes should be interpreted with clinical context.

Combine test patterns with clinical history and chronology.

Slide 58 · Case exercise: An asymptomatic abnormal enzyme result

Teaching vignette: A patient feels well but has newly abnormal AST and ALT.

No overt symptoms

AST / ALT elevated

Consider occult hepatocyte injury

The absence of symptoms is compatible with hepatic injury.

AST and ALT belong to the integrity domain.

The result cannot, alone, identify a specific etiology.

Slide 59 · Case exercise: An excretory-pattern abnormality

Teaching vignette: Serum bilirubin, ALP and GGT are reported as increased.

Excretory analytes ↑

Biliary function questioned

Evaluate cause and context

Bilirubin, ALP and GGT belong to the excretory panel.

Bile-flow disturbance is one route to clinically important dysfunction.

An excretory pattern directs attention to the biliary handling pathway.

Slide 60 · Case exercise: Loss of synthetic capacity

Teaching vignette: Serum albumin is low and clotting times are prolonged.

Synthesis markers abnormal

Hepatic capacity questioned

Assess for decompensation

Albumin and coagulation tests assess synthetic function.

These findings differ from isolated aminotransferase elevation.

Clinical interpretation must consider other possible causes.

Slide 61 · Case exercise: An extrahepatic cause

Teaching vignette: A patient with heart failure develops abnormal liver tests.

Cardiac disorder

Secondary hepatic damage

Abnormal liver panel

Heart failure illustrates a liver injury whose origin is extrahepatic.

The initiating disorder lies outside the liver.

Assessment must integrate hemodynamic and hepatic information.

Slide 62 · Integrated pathologic assessment

Anatomy, cause, injury, function and time should be considered together.

Etiology

Anatomical site

Functional category

Clinical course

Do not confuse injury location with its etiology.

Do not confuse enzyme elevation with organ-level failure.

A rational overview must account for functional reserve.

Slide 63 · Five high-yield distinctions

These distinctions govern interpretation across the liver disease curriculum.

Portal vs central

Position defines the acinar axis

Blood vs bile

Separate and opposing flows

Primary vs secondary

Site of origin differs

Injury vs function

Enzymes ≠ synthesis

Silent vs overt

Reserve delays manifestations

Acute vs insidious

Time course matters

A normal clinical appearance does not exclude liver damage.

Laboratory tests should be grouped by physiological domain.

Combine anatomic location, laboratory domain and time course.

Slide 64 · References and source boundaries

Primary source and scope of the lecture.

Primary reference

Robbins, Cotran & Kumar: Pathologic Basis of Disease, 11th ed. (2026), Chapter 18

Teaching scope

General Features of Liver Disease; assigned parent anatomy; Table 18.1; brief context from adjacent sections

Original topic starts on page 749.

Normal anatomy and Table 18.1 supplied supporting material.

Detailed disease-specific mechanisms are reserved for their respective topics.